2019 ATVB Plenary Lecture: Interleukin-2 Therapy in Cardiovascular Disease: The Potential to Regulate Innate and Adaptive Immunity. (2020)

First Author: Zhao TX
Attributed to:  Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/atvbaha.119.312287

PubMed Identifier: 32078364

Publication URI: http://europepmc.org/abstract/MED/32078364

Type: Journal Article/Review

Volume: 40

Parent Publication: Arteriosclerosis, thrombosis, and vascular biology

Issue: 4

ISSN: 1079-5642